Montesi A, Pesaresi A, Maggi S, Boschittari G, Gardoni R, Dubini L
Servizio di Radiologia e Diagnostica per Immagini, Ospedale Regionale Umberto I Torrette, USL n. 12, Ancona.
Radiol Med. 1995 Mar;89(3):282-6.
This work was aimed at investigating the cost-effectiveness of body CT, toward better equipment allocation in a given area. CT economics were calculated taking into account four main parameters: equipment, drugs, sanitary material and personnel. The biological cost in terms of radiation exposure was calculated on the effective dose. Quality was evaluated by comparing it with that of our standard examinations and on the basis of the diagnostic yield according to the index of radiological diagnoses by the American College of Radiology (ACR). The economic cost of chest CT was It. L. 257,240, that of abdominal CT was It. L. 365,000 and that of both regions It. L. 464,620. The effective dose was relatively high, i.e., 15.2 mSV for chest CT, 18.65 mSV in men and 27.46 mSV in women for abdominal CT and finally 27.38 mSV in men and 33.59 in women for chest-abdominal CT. The coded diagnoses were positive in approximately 60% of the cases examined consecutively; positivity was related to clinically relevant conditions in most of the cases. The economics and the biological cost of body CT exams were closely related to exam quality, whose standard was high. The high rate of positive findings and the clinical relevance of the condition make an indirect indicator of high quality and of accurate patients selection. To conclude, the allocation of CT equipment in a given area should be preceded by a careful cost-effectiveness analysis, considering optimized equipment use as related to local clinical needs.
这项工作旨在研究全身CT的成本效益,以便在特定区域实现更好的设备配置。计算CT的经济性时考虑了四个主要参数:设备、药物、卫生材料和人员。根据有效剂量计算辐射暴露方面的生物成本。通过与我们的标准检查进行比较,并根据美国放射学会(ACR)的放射学诊断指数得出的诊断率来评估质量。胸部CT的经济成本为257,240意大利里拉,腹部CT为365,000意大利里拉,胸部和腹部联合检查为464,620意大利里拉。有效剂量相对较高,即胸部CT为15.2毫希沃特,腹部CT男性为18.65毫希沃特、女性为27.46毫希沃特,最后胸部 - 腹部联合检查男性为27.38毫希沃特、女性为33.59毫希沃特。在连续检查的病例中,编码诊断约60%为阳性;在大多数病例中,阳性与临床相关情况有关。全身CT检查的经济性和生物成本与检查质量密切相关,其质量标准较高。高阳性发现率和病情的临床相关性间接表明了高质量和准确的患者选择。总之,在特定区域配置CT设备之前,应进行仔细的成本效益分析,考虑根据当地临床需求优化设备使用。